Klaria Competitors and Similar CompaniesClear all
Halozyme Therapeutics's competitors and similar companies include Puma Biotechnology.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | |
Founding Date | Founding Date 1998 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Los Angeles, US HQ |
Employees | Employees 373157% increase | Employees 27214% decrease |
Valuation ($) | Valuation ($) 6.4 b | Valuation ($) 136.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) |
Cost of goods | Cost of goods $228.8m (FY, 2025) | Cost of goods $58.2m (FY, 2025) |
Gross profit | Gross profit $1.2b (FY, 2025) | Gross profit $170.2m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 171.9m | Total funding raised $ 172m |
For sources of this data, please see the company profile
View Company Profiles
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company